![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://cdnintech.com/media/chapter/41807/1512345123/media/image5.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://cdnintech.com/media/chapter/41807/1512345123/media/image11.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
![Frontiers | Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate Frontiers | Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate](https://www.frontiersin.org/files/Articles/1123934/fendo-14-1123934-HTML-r1/image_m/fendo-14-1123934-g001.jpg)
Frontiers | Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate
![Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer | Scientific Reports Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-20319-z/MediaObjects/41598_2022_20319_Fig1_HTML.png)
Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer | Scientific Reports
![POCKET.MD - PSA DT Calculator for iPhone, PSA DT CALCULATOR è la nuova app di Janssen che accompagna il medico nella valutazione del tumore a... POCKET.MD - PSA DT Calculator for iPhone, PSA DT CALCULATOR è la nuova app di Janssen che accompagna il medico nella valutazione del tumore a...](http://www.pocket.md/images/appImages/screenshots/3046_668718553.jpeg)
POCKET.MD - PSA DT Calculator for iPhone, PSA DT CALCULATOR è la nuova app di Janssen che accompagna il medico nella valutazione del tumore a...
![Five-year Follow-up of Trial of Replication-competent Adenovirus-mediated Suicide Gene Therapy for Treatment of Prostate Cancer: Molecular Therapy Five-year Follow-up of Trial of Replication-competent Adenovirus-mediated Suicide Gene Therapy for Treatment of Prostate Cancer: Molecular Therapy](https://www.cell.com/cms/attachment/2083545739/2073243834/gr1.jpg)
Five-year Follow-up of Trial of Replication-competent Adenovirus-mediated Suicide Gene Therapy for Treatment of Prostate Cancer: Molecular Therapy
![Frontiers | Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practice Frontiers | Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practice](https://www.frontiersin.org/files/Articles/1266369/fonc-13-1266369-HTML/image_m/fonc-13-1266369-g002.jpg)